KR960005828B1 - Process for preparation of pyridine derivatives - Google Patents

Process for preparation of pyridine derivatives Download PDF

Info

Publication number
KR960005828B1
KR960005828B1 KR1019920014041A KR920014041A KR960005828B1 KR 960005828 B1 KR960005828 B1 KR 960005828B1 KR 1019920014041 A KR1019920014041 A KR 1019920014041A KR 920014041 A KR920014041 A KR 920014041A KR 960005828 B1 KR960005828 B1 KR 960005828B1
Authority
KR
South Korea
Prior art keywords
formula
compound
derivative
pyridine
reaction
Prior art date
Application number
KR1019920014041A
Other languages
Korean (ko)
Other versions
KR940003935A (en
Inventor
김상호
박호진
이강노
Original Assignee
주식회사코오롱
하기주
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사코오롱, 하기주 filed Critical 주식회사코오롱
Priority to KR1019920014041A priority Critical patent/KR960005828B1/en
Publication of KR940003935A publication Critical patent/KR940003935A/en
Application granted granted Critical
Publication of KR960005828B1 publication Critical patent/KR960005828B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

The pyridine derivative, 3,5-dimethyl-4-methoxy-2-hydroxymethyl pyridine(I), is prepared by : (a) making pyridinon derivative(VIII) from pentenon derivative(IV); (b) making chloropyridine derivative(IX) from the reaction with POCl3 or PCl5; (c) making methoxy pyridine derivative(X) from the reaction with metal alkoxyde such as sodium alkoxyde or potassium alkoxyde; (d) hydrogenating under the catalyst of Pd/C and 1-20 kg/cm3 hydrogen pressure.

Description

피리딘 유도체의 제조방법Method for preparing pyridine derivative

본 발명은 위산분비 억제특성을 갖는 벤즈이미졸 유도체의 제조에 사용되는 아래 구조식(I)의 피리딘 유도체의 제조방법에 관한 것이다.The present invention relates to a method for preparing a pyridine derivative of formula (I) below used in the preparation of benzimidazole derivatives having gastric acid secretion inhibitory properties.

아래 구조식(A)의 벤드이미다졸 유도체는 위궤양 및 십이지장궤양을 포함해서 위장관의 세포 보호 목적으로 사용되는 화합물로서, 그 제조방법은 영국 특허 제1,500,043호, 제1,525,958호, 미국특허 제4,182,766호 및 제4,255,431호 등에 기술되어 있는 일반명이 오메프라졸인 공지의 화합물이다.Benmidimidazole derivatives of the following structural formula (A) are compounds used for the purpose of protecting the gastrointestinal tract, including gastric ulcer and duodenal ulcer, and methods for preparing the same are described in British Patent Nos. 1,500,043, 1,525,958, US Pat. No. 4,182,766 and No. 4,255,431 and the like are known compounds whose common name is omeprazole.

위 구조식(A)의 벤즈이미다졸 유도체는 일반적으로 머캡토 벤즈이미다졸 유도체와 클로로메틸 피리딘을 결합시켜 이루어지는 화합물이며, 오메프라졸의 제조에 있어서 4-메톡시-3,5-디메틸-2-히드록시메틸 피리딘은 필수적인 중간체로서, 이를 제조하는 공지의 방법은 대한민국 특허공보 88-91 등에 기술되어 있는데 이들 제조방법을 살펴보면 다음과 같다.Benzimidazole derivatives of the above structural formula (A) are generally compounds formed by combining mercapto benzimidazole derivatives with chloromethyl pyridine, and in the preparation of omeprazole, 4-methoxy-3,5-dimethyl-2-hydroxy Methyl pyridine is an essential intermediate, and a known method for preparing the same is described in Korean Patent Publication No. 88-91, which is described below.

위 공지의 방법은 3,5-루티딘 또는 2,3,5-콜리딘을 출발물질로 하여 과산화수소와 반응시켜 피리딘-N-옥사이드를 얻고, 니트로화제와 반응시켜 메톡시기가 도입된 피리딘-N-옥사이드 화합물을 얻은 다음, 황산 디메틸 및 유리 라디칼을 사용하거나 무수 아세트산[(CH3CO)2O]과 반응시킨 후 가수분해반응을 시켜 목적생성물을 얻는 방법이다.The above known method is reacted with hydrogen peroxide using 3,5-lutidine or 2,3,5-collidine as a starting material to obtain pyridine-N-oxide, and reacted with a nitrating agent to introduce pyridine-N into which a methoxy group is introduced. After obtaining -oxide compound, using dimethyl sulfate and free radicals or reacting with acetic anhydride [(CH 3 CO) 2 O] and then hydrolysis reaction to obtain the desired product.

그러나 이와 같은 공지의 방법은, 전체 합성공정이 피리딘환의 각 위치에 적당한 기를 선택적으로 도입하기 위해 산화, 환원, 도입, 치환반응 등의 연속조작이 필요하므로 반응조작이 복잡하고 효과적이지 못하며 수율이 저조한 문제점을 지니고 있다. 또한 합성중간체로 생성되는 니트로-피리딘-N-옥사이드 화합물은 발암성과 돌연변이원성 성질을 갖는 인체에 유해한 물질이라는 단점이 있으며, 2,3,5-콜리딘의 경우는 고가이며 그의 합성시에도 3,5-루티딘과 같은 물질을 출발물질로 하여 2번 위치에 선택적으로 메틸기를 도입하는 반응이 선행되어야 하는 단점이 있다.However, such a known method requires a continuous operation such as oxidation, reduction, introduction, and substitution reaction in order to selectively introduce an appropriate group at each position of the pyridine ring, so that the reaction operation is complicated and ineffective, and yield is low. I have a problem. In addition, the nitro-pyridine-N-oxide compound produced as a synthetic intermediate has the disadvantage of being harmful to the human body having carcinogenic and mutagenic properties, and 2,3,5-collidine is expensive and 3, There is a disadvantage that a reaction of selectively introducing a methyl group at position 2 with a starting material such as 5-lutidine must be preceded.

따라서, 본 발명자들은, 상기 공지방법의 단점이 배제된 효율적이며 그 공정이 간편하고 경제적인 일반식(I)의 4-메톡시-3,5-디메틸-2-히드록시메틸 피리딘의 새로운 제조방법을 발명하여 본 발명을 완성하였다. 곧, 구체적으로 말하면, 본 발명은 적당한 위치에 원하는 기로 치환되어있는 지방족 엔-온(ene-one) 화합물과 아세틸 라디칼 유도체를 축합반응시키고, 고리화치환반응 및 수소화반응 등을 통하여 구조식(I)의 목적화합물을 제조하는 효율적이고 새로운 제조방법이다.Therefore, the inventors of the present invention provide a novel method for preparing 4-methoxy-3,5-dimethyl-2-hydroxymethyl pyridine of general formula (I), in which the disadvantages of the above known method are eliminated. Invented to complete the present invention. In other words, specifically, the present invention condensates an aliphatic ene-one compound and an acetyl radical derivative, which is substituted with a desired group at a suitable position, and is represented by the structural formula (I) through a cyclosubstitution reaction and a hydrogenation reaction. It is an efficient and new manufacturing method for preparing target compound

본 발명을 더 구체적으로 설명하면, 구조식(I)의 화합물은 다음이 공정에 의해서 제조된다.In more detail, the compound of formula (I) is prepared by the following process.

본 발명의 반응경로에 있어서 첫번째 반응단계는, 아래 구조식(II)의 3-펜타논과 에틸 포르메이트를 나트륨 메톡시드를 사용하여 반응시키고 염산수용액으로 처리하여 아래 구조식(III)의 화합물을 형성시키고, 곧이서 메톡시드 음이온으로 반응시켜 아래 구조식(IV)의 2,4-디메틸-1-메톡시-1-펜텐-3-온을 합성하는 공정으로 진행된다.In the reaction route of the present invention, the first reaction step, 3-pentanone of the formula (II) and ethyl formate is reacted using sodium methoxide and treated with aqueous hydrochloric acid to form a compound of the formula (III) The reaction proceeds to a process of synthesizing 2,4-dimethyl-1-methoxy-1-penten-3-one of formula (IV) below by reacting with a methoxide anion.

두번째 반응단계는 위의 구조식(IV)의 펜텐온 유도체를 금속 촉매를 가하여 아래 구조식(V)의 아세틸 라디칼과 저온반응을 시켜서 다음 구조식(V) 및 (VII)의 중간체를 형성시키고, 암모니움 히드로시와 환류반응 또는 암모니아(NH3) 가압반응시켜서 다음 구조식(VIII)의 3,5-디메틸-2-벤질옥시메틸-4-피리디논 화합물을 제조하는 반응으로서, 아세틸 라디칼로서는 벤질옥시아세틸 클로리드, 브로미드, 아이오디드 및 무수물을 사용할 수 있으며, 본 발명에 있어서 특징적인 반응단계이다.In the second reaction step, the pentenone derivative of the above formula (IV) is subjected to a low temperature reaction with the acetyl radical of the following formula (V) by adding a metal catalyst to form an intermediate of the following formulas (V) and (VII), and ammonia hydro Reaction of Si with reflux or pressurization with ammonia (NH 3 ) to produce 3,5-dimethyl-2-benzyloxymethyl-4-pyridinone compound of the following formula (VIII), wherein the acetyl radical is benzyloxyacetyl chloride. , Bromides, iodides and anhydrides may be used and are characteristic reaction steps in the present invention.

식중 X는 Cl, Br, I 또는이다.Wherein X is Cl, Br, I or to be.

세번째 반응단계는, 피리딘환의 4번 위치에 메톡시기를 치환시키는 반응으로서, 위의 구조식(VIII)의 피리디논 유도체를 불활성용매 하에서 염소화제와 반응시켜서 아래 구조식(IX)의 4-클로로-3,5-디메틸-6-벤질옥시메틸 피리딘을 제조하고, 극성 비양자성 유기용매하에서 메톡시드 음이온과 반응을 거쳐서 피리딘환의 4번위치에 메톡시기를 도입시킴으로써 아래 구조식(X)의 4-메톡시-3,5-디메틸-6-벤질옥시메틸 피리딘을 제조하는 공정이다.The third reaction step is a reaction for substituting a methoxy group at position 4 of the pyridine ring, by reacting a pyridinone derivative of the above formula (VIII) with a chlorinating agent under an inert solvent to form 4-chloro-3, 5-Dimethyl-6-benzyloxymethyl pyridine is prepared and reacted with a methoxide anion in a polar aprotic organic solvent to introduce a methoxy group at position 4 of the pyridine ring to form 4-methoxy-3 of formula (X) below. , 5-dimethyl-6-benzyloxymethyl pyridine.

본 발명의 목적화합물이며 구조식(A)의 오메프라졸 합성에 있어서 중요한 출발물질인, 아래 구조식(I)의 피리딘 유도체를 제조하는 마지막 반응 단계는, 구조식(X)의 피리딘 유도체를 비산성 용매에서 수소화반응을 진행시켜 벤질옥시기를 제거함으로써 구조식(I)의 3,5-디메틸-4-메톡시-2-히드록시메틸 피리딘을 제조하는 방법이다.The final reaction step of preparing the pyridine derivative of formula (I), which is the target compound of the present invention and an important starting material for the synthesis of omeprazole of formula (A), is the hydrogenation of pyridine derivative of formula (X) in a non-acidic solvent. This is a method for producing 3,5-dimethyl-4-methoxy-2-hydroxymethyl pyridine of formula (I) by advancing to remove benzyloxy group.

위와 같은 본 발명의 반응공정을 더욱 상세히 설명하면 다음과 같다.Referring to the reaction process of the present invention as described above in more detail as follows.

구조식(IV)의 펜텐온 유도체는 3-펜텐온을 편리하게는 디에틸 에테르, 테트라히드로푸란 등의 비양자성 유기용매에서 나트륨메톡시드를 사용하여 에틸 포르메이트와 반응시키고, 염산수용액으로 산성처리한 후 메톡시드 음이온을 가하여 환류반응시켜서 제조할 수 있다. 상기의 축합반응은 0℃에서 상온 사이의 범위에서 1-6시간 반응시키고 구조식(III)의 화합물로부터 메톡시기를 도입하기 위해서는 농황산과 메탄올로부터 메톡시드 음이온을 형성시키고 벤젠, 톨루엔 등의 불활성 유기 용매 하에서 50℃에서 환류온도까지 3-6시간 반응시켜서 제조할 수 있다. 본 발명에 있어서 특징적인 반응단계인 구조식(VIII)의 제조조건은 구조식(IV)의 펜텐온 유도체를 리튬 비스(트리메틸실릴)아미드, 보론 트리플로리드, 징크 클로리드 등의 금속촉매를 사용하여 아세틸 라디칼로서 벤질옥시아세틸 클로리드, 벤질옥시아세틸 브로미드 또는 벤질옥시아세틸 무수물과 반응시킴으로써 구조식(IV)화합물의 4번째 위치에 선택적으로 벤질옥시아세틸기를 도입시켜 구조식(VI) 및 (VII)의 화합물을 제조할 수 있다. 반응은 디에틸 에테르 또는 테트라히드로퓨란 등의 비양자성 유기용매를 사용하여 -78에서 -20℃사이에서 1-3시간 동안 저온반응을 시킨다. 이때 구조식(VI)의 펜텐온 유도체와 구조식(VII)의 피란온 유도체 혼합물이 생성되는데 이와 같은 화합물은 헥산/에틸 아세테이트(3/1)의 전개용매를 사용하고 컬럼크로마토그래피를 시행하여 분리할 수 있는데 편리하게는 분리조작 없이 혼합물의 형태로 다음 반응을 진행시킬 수 있다. 별도의 분리조작 없이 상기의 혼합물에 암모니움히드록시 알코올용액을 가하고 환류반응을 진행시켜 쉽게 구조식(VIII)의 화합물을 제조할 수 있다.The pentenone derivative of formula (IV) is a compound in which 3-pentenone is conveniently reacted with ethyl formate using sodium methoxide in an aprotic organic solvent such as diethyl ether or tetrahydrofuran, and acidified with aqueous hydrochloric acid solution. After the addition of methoxide anion it can be prepared by reflux reaction. The condensation reaction is carried out for 1-6 hours at a temperature between 0 ° C. and room temperature. In order to introduce a methoxy group from the compound of formula (III), a methoxide anion is formed from concentrated sulfuric acid and methanol, and an inert organic solvent such as benzene and toluene. It can be manufactured by making it react for 3-6 hours from 50 degreeC to reflux temperature under the following. In the present invention, the conditions for the preparation of the structural formula (VIII), which is a characteristic reaction step, are carried out using the pentenone derivative of the structural formula (IV) using a metal catalyst such as lithium bis (trimethylsilyl) amide, boron trichloride, zinc chloride and the like. By reacting with a benzyloxyacetyl chloride, benzyloxyacetyl bromide or benzyloxyacetyl anhydride as a radical, a benzyloxyacetyl group is selectively introduced at the fourth position of the compound of formula (IV) to obtain the compounds of formulas (VI) and (VII). It can manufacture. The reaction is subjected to a low temperature reaction for 1-3 hours at -78 to -20 ° C using an aprotic organic solvent such as diethyl ether or tetrahydrofuran. At this time, a mixture of pentenone derivatives of formula (VI) and pyranone derivatives of formula (VII) is produced. Such compounds can be separated by using a developing solvent of hexane / ethyl acetate (3/1) and performing column chromatography. It is convenient to proceed to the next reaction in the form of a mixture without any manipulation. The compound of formula (VIII) can be easily prepared by adding ammonium hydroxy alcohol solution to the mixture and proceeding to reflux without any separate separation operation.

상기의 반응에서 제조된 구조식(VIII)의 피리딘온 유도체는 적당한 염소화반응과 알콕시 치환반응을 통해서 구조식(IX)의 4-메톡시-3,5-디메틸-6-벤질옥시메틸피리딘을 형성하는데, 염소화반응은 벤젠이나 톨루엔 등과 같은 불활성 유기용매하에서 포스포러스 옥시클로리드(POCl5) 또는 포스포러스 펜타클로리드(PCl3)등과 같은 염소화제를 사용하여 70-150℃에서 1-6시간 동안 반응을 진행시키며 구조식(X)의 화합물은 디메틸 포름아미드, 디메틸 아세트아미드 또는 디메틸 술폭시드와 같은 극성 비양자성 유기용매 내에서 나트륨 메톡시드, 칼륨 메톡시드 등의 금속 알콕시드와 50-80℃의 온도에서 4-6시간 동안 가온 교반을 시켜 4번 위치에 메톡시기를 도입시킴으로써 제조될 수 있다.The pyridinone derivative of formula (VIII) prepared in the above reaction forms 4-methoxy-3,5-dimethyl-6-benzyloxymethylpyridine of formula (IX) through suitable chlorination and alkoxy substitution reaction. The chlorination reaction is carried out for 1-6 hours at 70-150 ° C. using a chlorinating agent such as phosphorus octacycloide (POCl 5 ) or phosphorus pentachloride (PCl 3 ) in an inert organic solvent such as benzene or toluene. The compound of formula (X) was reacted with a metal alkoxide such as sodium methoxide and potassium methoxide in a polar aprotic organic solvent such as dimethyl formamide, dimethyl acetamide or dimethyl sulfoxide at a temperature of 50-80 ° C. It can be prepared by introducing a methoxy group at position 4 with warm stirring for -6 hours.

본 발명에 있어서 목적화합물인 구조식(I)의 피리딘 유도체는 통상의 수소화 반응 조건을 통해서 벤질 옥시기를 제거함으로서 고순도, 고수율로 얻을 수 있는 바, 에탄올과 같은 알코올 용액에서 팔라듐 또는 아연 등과 같은 촉매를 사용하여 수소압력 하에서 반응시켜서 제조할 수 있다. 수소화반응은 1-20kg/cm2의 수소압력에서 7-12시간 동안 교반을 시키며 바람직하게는 10%의 Pd/C 에탄올 용액 하에서 반응시키는 것이 좋다.In the present invention, the pyridine derivative of formula (I), which is the target compound, can be obtained in high purity and high yield by removing benzyl oxy group through ordinary hydrogenation reaction conditions, and thus, a catalyst such as palladium or zinc in an alcohol solution such as ethanol can be obtained. Can be prepared by reacting under hydrogen pressure. The hydrogenation reaction is stirred for 7-12 hours at a hydrogen pressure of 1-20kg / cm 2 and preferably reacted under 10% Pd / C ethanol solution.

본 발명의 진보된 제조공정에 의하여 고수율로 얻게 되는 구조식(I)의 화합물은 독일공개특허 제2,428,294호 및 제3,040,248호에 개시된 공지방법으로 티오닐클로리드와 반응시키면 다음 구조식(XI)의 클로로메틸 피리딘 유도체를 얻을 수 있다.The compound of formula (I) obtained in high yield by the advanced manufacturing process of the present invention is reacted with thionyl chloride by the known method disclosed in German Patent Nos. 2,428,294 and 3,040,248, and the chloro of formula (XI) Methyl pyridine derivatives can be obtained.

상술한 바와 같이, 본 발명은 3,5-루티딘 또는 2,3,5-콜리딘 등을 출발물질로 사용하여 산화, 치환반응등의 조작을 통해서 구조식(I)의 화합물을 얻는 공지의 방법보다 반응공정이 유용할 뿐 아니라 인체에 유해한 중간체의 형성없이 높은 수율로 직접 구조식(I)의 목적 화합물인 4-메톡시-3,5-디메틸-2-히드록시메틸 피리딘을 얻을 수 있는 경제적이고 진보된 새로운 제조방법이다.As described above, the present invention is a known method for obtaining the compound of formula (I) through the operation of oxidation, substitution reaction, etc. using 3,5-lutidine or 2,3,5-collidine as a starting material Not only is the reaction process more useful, it is economical to obtain 4-methoxy-3,5-dimethyl-2-hydroxymethyl pyridine, the target compound of formula (I), in high yield, without the formation of intermediates harmful to the human body. It is an advanced new manufacturing method.

다음의 실시예들은 본 발명을 구체적으로 설명하는 것이며, 본 발명을 제한하는 것은 아니다.The following examples illustrate the invention in detail, and do not limit the invention.

[실시예 1]Example 1

2,4-디메틸-1-메톡시-1-펜텐-3-온(IV)의 제조Preparation of 2,4-dimethyl-1-methoxy-1-penten-3-one (IV)

환류냉각기와 교반기가 장치된 반응기에 무수 디에틸 에테르 1L를 넣고 나트륨 메톡시드 60g을 가하고 용액의 온도를 0℃로 냉각한 후, 동일 온도에서 110ml의 3-펜텐온과 89ml의 에틸 포르메이트를 가하여 동일온도에서 3시간 교반한 후 생성된 침전물을 여과하고 세척한 후 건조하였다. 이 화합물을 물에 녹이고 1N-HCl로 산성화시킨 다음 디클로메탄으로 3회에 걸쳐 추출하고 얻어지는 유기층을 황산 마그네슘으로 건조하고 농축하여 구조식(III)의 연황색 고체물질을 얻었다. 여기에 벤젠 250ml를 가하여 녹인 다음 메탄올 45ml와 진한 황산 10ml를 넣은 후 5시간 동안 환류 교반하였다. 벤젠층을 황산 마그네슘으로 건조한 후 감압농축하여 벤젠을 제거하여 무색의 액체상태로 표제의 화합물(IV) 123.3g을 얻었다.1 L of anhydrous diethyl ether was added to a reactor equipped with a reflux condenser and agitator, 60 g of sodium methoxide was added thereto, and the temperature of the solution was cooled to 0 ° C. Then, 110 ml of 3-pentenone and 89 ml of ethyl formate were added at the same temperature. After stirring for 3 hours at the same temperature, the resulting precipitate was filtered, washed and dried. The compound was dissolved in water, acidified with 1N-HCl, extracted three times with dichloromethane, and the obtained organic layer was dried over magnesium sulfate and concentrated to obtain a pale yellow solid material of formula (III). 250 ml of benzene was added thereto to dissolve, 45 ml of methanol and 10 ml of concentrated sulfuric acid were added thereto, and the mixture was stirred under reflux for 5 hours. The benzene layer was dried over magnesium sulfate and concentrated under reduced pressure to remove benzene to give 123.3 g of the titled compound (IV) as a colorless liquid.

수율 : 87%Yield: 87%

H NMR(CDCl3)δ : 7.25(s,1H), 3.85(s,3H), 2.64(m,2H), 1.80(s,3H), 1.20(s,3H)H NMR (CDCl 3 ) δ: 7.25 (s, 1H), 3.85 (s, 3H), 2.64 (m, 2H), 1.80 (s, 3H), 1.20 (s, 3H)

[실시예 2]Example 2

3,5-디메틸-2-벤질옥시메틸-4-피리디온(VIII)의 제조Preparation of 3,5-dimethyl-2-benzyloxymethyl-4-pyridionone (VIII)

2,4-디메틸-1-메톡시-1-펜텐-3-온(IV)에 26g을 500ml의 테트라히드로퓨란에 녹이고 반응액의 온도를 -78℃로 냉각시킨 후 리튬 버스(트리메틸실릴(아미드 38ml를 가하고 30분 교반한 후 여기에 벤질옥시아세틸클로라이드 20g을 서서히 가하고 같은 온도에서 1시간 동안 교반한 후 여기에 포화시킨 암모늄 클로리드 용액을 가하고 디에틸 에테르로 추출한 후 유기층을 감압 농축하여 무색의 액체물질로 구조식(VI) 및 (VII)의 혼합물을 얻었다. 앞에서 얻은 혼합 화합물에 메탄올과 암모늄 히드록시를 각각 200ml씩 가하여 용해시킨 후 3시간 동안 환류 교반하고 용매를 감압 농축한 다음 에틸아세테이트 500ml를 가하여 침전물을 형성시키고 이 침전물을 여과 및 건조시켜 황색의 고체물질로 표제화합물(VIII)을 18.4g(수율 : 75%)을 얻었다.After dissolving 26 g in 2,4-dimethyl-1-methoxy-1-penten-3-one (IV) in 500 ml of tetrahydrofuran and cooling the reaction solution to -78 ° C, lithium bus (trimethylsilyl (amide) After adding 38 ml and stirring for 30 minutes, 20 g of benzyloxyacetyl chloride was slowly added thereto, stirred at the same temperature for 1 hour, and then saturated ammonium chloride solution was added thereto, extracted with diethyl ether, and the organic layer was concentrated under reduced pressure. As a liquid, a mixture of structural formulas (VI) and (VII) was obtained, and 200 ml of methanol and ammonium hydroxy were added to the mixed compound to dissolve, and the mixture was stirred under reflux for 3 hours, the solvent was concentrated under reduced pressure, and 500 ml of ethyl acetate was added. The precipitate was added to form a precipitate, which was filtered and dried to yield 18.4 g (yield: 75%) of the title compound (VIII) as a yellow solid.

융점 : 148-150℃Melting Point: 148-150 ℃

H NMR(CDCl3)δ : 10.50(s,NH), 9.4(m,6H), 4.51(d,4H), 2.00(d,6H)H NMR (CDCl 3 ) δ: 10.50 (s, NH), 9.4 (m, 6H), 4.51 (d, 4H), 2.00 (d, 6H)

[실시예 3]Example 3

실시예 2와 동일한 반응 조건을 이용하여 반응을 실시하되, 피리디온 유도체를 합성하는 과정에 있어서 암모니움 히드록시 대신에 5kg/cm2의 암모니아가스 압력을 사용하여 100℃의 반응온도에서 반응을 시킨 결과 3,5-디메틸-2-벤질옥시메틸-4-피리디온(VIII)을 82%의 수율로 얻었다.The reaction was carried out using the same reaction conditions as in Example 2, but in the process of synthesizing pyridinone derivatives, the reaction was carried out at a reaction temperature of 100 ° C. using ammonia gas pressure of 5 kg / cm 2 instead of ammonium hydroxy. The resulting 3,5-dimethyl-2-benzyloxymethyl-4-pyridion (VIII) was obtained in a yield of 82%.

[실시예 4]Example 4

3,5-디메틸-4-클로로-6-벤질옥시메틸피리딘(IX)의 제조Preparation of 3,5-dimethyl-4-chloro-6-benzyloxymethylpyridine (IX)

실시예 2에서 얻은 3,5-디메틸-2-벤질옥시메틸-4-피리딘온 20g을 톨루엔 100ml에 녹이고 여기에 포스포러스 옥시클로리드 22ml를 가하여 2시간 동안 환류 교반하였다. 반응이 완결되면 감압증류하여 용매를 제거하고 잔류물에 디에틸 에테르와 포화시킨 중조용액을 가하여 추출한 후 유기층을 황산 마그네슘으로 건조시키고 감압 증류하여 표제의 화합물(IX)의 3,5-디메틸-4-클로로-6-벤질옥시메틸 피리딘 18.86g을 얻었다.20 g of 3,5-dimethyl-2-benzyloxymethyl-4-pyridinone obtained in Example 2 was dissolved in 100 ml of toluene, and 22 ml of phosphorus oxcyclolide was added thereto, followed by stirring under reflux for 2 hours. After completion of the reaction, the mixture was distilled under reduced pressure to remove the solvent, and extracted with diethyl ether and saturated sodium bicarbonate solution. The organic layer was dried over magnesium sulfate and distilled under reduced pressure to obtain 3,5-dimethyl-4 of the title compound (IX). 18.86 g of -chloro-6-benzyloxymethyl pyridine was obtained.

수율 : 91%Yield: 91%

H NMR(CDCl3)δ : 8.22(s,1H), 7.33(m, 5H), 4.70(d,4H), 2.33(d,6H)H NMR (CDCl 3 ) δ: 8.22 (s, 1H), 7.33 (m, 5H), 4.70 (d, 4H), 2.33 (d, 6H)

[실시예 5]Example 5

3,5-디메틸-4-메톡시-6-벤질옥시메틸 피리딘(X)의 제조Preparation of 3,5-dimethyl-4-methoxy-6-benzyloxymethyl pyridine (X)

나트륨 메톡시드 6.2g을 디메틸 술폭시드 500ml에 가하여 메톡시드 음이온을 형성시키고 여기에 4-클로로-3,5-디메틸-6-벤질옥시메틸 피리딘 20g을 가한 다음 60℃에서 6시간 동안 교반한 후 디에틸 에테르로 추출하고 농축하여, 무색의 액체물질인 표제화합물(X)를 17.4g을 얻었다.6.2 g of sodium methoxide was added to 500 ml of dimethyl sulfoxide to form methoxide anion, 20 g of 4-chloro-3,5-dimethyl-6-benzyloxymethyl pyridine was added thereto, followed by stirring at 60 ° C. for 6 hours, followed by di Extraction with ethyl ether and concentration gave 17.4 g of the title compound (X) as a colorless liquid substance.

수율 : 89%Yield: 89%

H NMR(CDCl3)δ : 8.24(s, 1H), 7.35(m,5H), 4.62(d,4H), 3.76(d,3H), 2.30(d,6H)H NMR (CDCl 3 ) δ: 8.24 (s, 1H), 7.35 (m, 5H), 4.62 (d, 4H), 3.76 (d, 3H), 2.30 (d, 6H)

[실시예 6]Example 6

3,5-디메틸-4-메톡시-2-히드록시메틸 피리딘(I)의 제조Preparation of 3,5-dimethyl-4-methoxy-2-hydroxymethyl pyridine (I)

압력반응기에서 3.5-디메틸-4-메톡시-6-벤질옥시메틸 피리딘(X) 15.8g을 10%의 Pd/C 에탄올 용액 600ml에 가하고 5kg/cm2의 수소 압력하에서 12시간 교반하여 반응을 완결시킨 후, Pd/C을 여과하여 제거한 후 용매를 감압 농축시켜 무색의 액체물질인 목적화합물(I)을 9.2g을 얻었다.In a pressure reactor, 15.8 g of 3.5-dimethyl-4-methoxy-6-benzyloxymethyl pyridine (X) was added to 600 ml of 10% Pd / C ethanol solution and stirred for 12 hours under hydrogen pressure of 5 kg / cm 2 to complete the reaction. After Pd / C was filtered off, the solvent was concentrated under reduced pressure to obtain 9.2 g of the target compound (I) as a colorless liquid substance.

수율 : 92%Yield: 92%

H NMR(CDCl3) : 8.17(s,1H), 4.60(s, 3H), 3.76(s,3H), 2.24(s,3H), 2.19(s,3H)H NMR (CDCl 3 ): 8.17 (s, 1H), 4.60 (s, 3H), 3.76 (s, 3H), 2.24 (s, 3H), 2.19 (s, 3H)

[실시예 7]Example 7

3,5-디메틸-4-메톡시-2-클로로메틸 피리딘 염산염(XI)의 제조Preparation of 3,5-dimethyl-4-methoxy-2-chloromethyl pyridine hydrochloride (XI)

냉각조가 부착된 반응조에 디클로로메탄 100ml에 넣고 여기에 3,5-디메틸-4-메톡시-2-히드록시메틸 피리딘 12g을 넣어 녹인 후 반응용액의 온도를 0℃로 냉각하고 티오닐 클로리드 12ml를 천천히 가하고 상온에서 5시간 교반하였다. 미반응의 티오닐 클로리드 및 용매를 감압 증류시켜서 백색의 고체물질인 표제 화합물을 15.2g을 얻었다.Put 100ml of dichloromethane into the reaction tank to which the cooling tank was attached, and add 12g of 3,5-dimethyl-4-methoxy-2-hydroxymethyl pyridine to dissolve it, and then cool the reaction solution to 0 ° C and 12ml of thionyl chloride. Was added slowly and stirred at room temperature for 5 hours. Unreacted thionyl chloride and the solvent were distilled off under reduced pressure to obtain 15.2 g of the title compound as a white solid.

수율 : 95%Yield: 95%

H NMR(CDCl3) : 8.21(s,1H), 4.92(s, 2H), 3.75(s,3H), 2.24(s,3H), 2.18(s,3H)H NMR (CDCl 3 ): 8.21 (s, 1H), 4.92 (s, 2H), 3.75 (s, 3H), 2.24 (s, 3H), 2.18 (s, 3H)

[비교 실시예 1]Comparative Example 1

대한민국 특허 공보 88-91호에 기재된 방법에 따라 2,3,5-콜리딘 100g을 초산과 반응시켜 2,3,5-콜리딘-N-옥사이드를 합성하고, 황산 및 질산 혼합용액의 니트로화 용액과 반응시킨 후 메탄올 중의 메톡시드 음이온과 반응시켜 4-메톡시-2,3,5-트리메틸-피리딘-N-옥사이드를 제조하였다. 공지의 방법에 따라 무수초산과 반응시킨 후 수산화나트륨으로 가수분해시키고 티오닐 클로라이드와 반응을 진행시켜 목적화합물인 3,5-디메틸-4-메톡시-2-클로로메틸 피리딘 56.9g(수율 : 31%)을 얻었다.According to the method described in Korean Patent Publication No. 88-91, 100 g of 2,3,5-collidine was reacted with acetic acid to synthesize 2,3,5-collidine-N-oxide, and nitration of a sulfuric acid and nitric acid mixed solution was performed. After reacting with the solution, it was reacted with methoxide anion in methanol to prepare 4-methoxy-2,3,5-trimethyl-pyridine-N-oxide. After reacting with acetic anhydride according to a known method, hydrolyzing with sodium hydroxide and proceeding with reaction with thionyl chloride, 56.9 g of the target compound 3,5-dimethyl-4-methoxy-2-chloromethyl pyridine (yield: 31 %) Was obtained.

Claims (9)

아래 구조식(I)로 나타낸 히드록시메틸 피리딘 유도체를 제조하는데 있어서, 아래 구조식(IV)의 펜텐온 유도체로부터 아래 구조식(VIII)의 피리딘온 유도체를 합성하여, 이를 염소화제와 반응시켜 아래 구조식(IX)의 클로로피리딘 유도체를 제조하고, 금속 알콕시드와 반응시켜 아래 구조식(X)의 메톡시드 피리딘 유도체를 제조한 후 수소화반응을 시켜, 3,5-디메틸-4-메톡시-2-히드록시메틸 피리딘(I)을 제조하는 것을 특징으로 하는 제조방법.In preparing the hydroxymethyl pyridine derivative represented by the following structural formula (I), a pyridinone derivative of the following structural formula (VIII) is synthesized from the pentenone derivative of the following structural formula (IV), and reacted with a chlorinating agent to give the following structural formula (IX) Chloropyridine derivatives of n) were prepared and reacted with metal alkoxides to produce methoxide pyridine derivatives of the following formula (X), followed by hydrogenation to give 3,5-dimethyl-4-methoxy-2-hydroxymethyl A process for producing pyridine (I). 제1항에 있어서, 구조식(VIII)의 화합물의 제조는 구조식(IV)의 화합물을 아래 구조식(V)의 벤질옥시아제틸 라디칼과 촉매 하에서 반응시켜 아래 구조식(IV) 및 (VII)의 화합물을 제조한 다음, 알코올 용매 하에서 암모니아 유도체와 반응시킴을 특징으로 하는 제조방법.The process of claim 1, wherein the preparation of the compound of formula (VIII) comprises reacting the compound of formula (IV) with a benzyloxyazyl radical of formula (V) under a catalyst to react the compounds of formulas (IV) and (VII) And then reacting with the ammonia derivative in an alcohol solvent. 식중 X는 Cl, Br, I 또는이다.Wherein X is Cl, Br, I or to be. 제1항에 있어서, 금속 알콕시드가 나트륨 메톡시드 또는 칼륨 메톡시드임을 특징으로 하는 구조식(I)의 화합물의 제조방법.The process for preparing a compound of formula (I) according to claim 1, wherein the metal alkoxide is sodium methoxide or potassium methoxide. 제1항에 있어서, 염소화제로 POCl3또는 PCl3를 사용함을 특징으로 하는 제조방법.The method according to claim 1, wherein POCl 3 or PCl 3 is used as the chlorinating agent. 제1항에 있어서, 수호화반응은 Pd/C을 촉매로 하여 1-20kg/cm2의 수소압력에서 실시하는 것을 특징으로 하는 제조방법.The method according to claim 1, wherein the dehydration reaction is carried out at a hydrogen pressure of 1-20 kg / cm 2 using Pd / C as a catalyst. 제2항에 있어서, 암모니아 유도체와의 반응은 상압에서 암모니움 히드록시와 반응시키거나 5-10kg/cm2의 암모니아(NH3) 압력 하에서 반응시키는 것을 특징으로 하는 제조방법.The method according to claim 2, wherein the reaction with the ammonia derivative is reacted with ammonium hydroxy at normal pressure or under ammonia (NH 3 ) pressure of 5-10 kg / cm 2 . 제2항에 있어서, 벤질옥시아세틸 라디칼로는 벤질옥시아세틸 클로리드, 벤질옥시아세틸 브로미드 또는 벤질옥시아세틸 무수물인 것을 특징으로 하는 제조방법.3. The process according to claim 2, wherein the benzyloxyacetyl radical is benzyloxyacetyl chloride, benzyloxyacetyl bromide or benzyloxyacetyl anhydride. 제2항에 있어서, 촉매가 리튬 비스(트리메틸실릴)아미드, 보른 트리플로리드 또는 징크 클로리드임을 특징으로 하는 구조식(I)의 화합물의 제조방법.The process for preparing a compound of formula (I) according to claim 2, wherein the catalyst is lithium bis (trimethylsilyl) amide, boron trifluoride or zinc chloride. 제2항에 있어서, 알코올이 메탄올 또는 에탄올임을 특징으로 하는 구조식(I) 화합물의 제조방법.The process for preparing the compound of formula (I) according to claim 2, wherein the alcohol is methanol or ethanol.
KR1019920014041A 1992-08-05 1992-08-05 Process for preparation of pyridine derivatives KR960005828B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019920014041A KR960005828B1 (en) 1992-08-05 1992-08-05 Process for preparation of pyridine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019920014041A KR960005828B1 (en) 1992-08-05 1992-08-05 Process for preparation of pyridine derivatives

Publications (2)

Publication Number Publication Date
KR940003935A KR940003935A (en) 1994-03-14
KR960005828B1 true KR960005828B1 (en) 1996-05-01

Family

ID=19337521

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920014041A KR960005828B1 (en) 1992-08-05 1992-08-05 Process for preparation of pyridine derivatives

Country Status (1)

Country Link
KR (1) KR960005828B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7396441B2 (en) * 2002-02-22 2008-07-08 Aqua Innovations, Inc. Flow-through oxygenator

Also Published As

Publication number Publication date
KR940003935A (en) 1994-03-14

Similar Documents

Publication Publication Date Title
US6472532B1 (en) Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-OXO-1,4-dihydropyridine-2-carboxamide
KR960005828B1 (en) Process for preparation of pyridine derivatives
CN113278021B (en) Preparation method of 1, 7-diazaspiro [3.5] nonane-7-tert-butyl formate and oxalate thereof
EP0271275B1 (en) Trifluorohydroxyaromatic acid and preparation thereof
JP2979358B2 (en) Phenothiazine derivatives
JPS63264439A (en) Production of 3,5,6-trifluoro-4-hydroxyphthalic acid
JPS629098B2 (en)
KR0131051B1 (en) Process for preparing pyridine derivatives
JPS645034B2 (en)
JP2992334B2 (en) Process for producing 2,4,5-tribromopyrrole-3-carbonitrile compound as molluscicide
JPH0841029A (en) 3-substituted quinoline-5-carboxylic acid derivative and itsproduction
JP4321065B2 (en) Process for producing quinolinecarboxaldehyde derivative and its intermediate
KR950008527B1 (en) A process for the preparation of pyridine derivatives
WO1995022533A1 (en) Process for producing 3-isoxazolecarboxylic acid
CN111320579B (en) Preparation method of 8-amide-5-halogenated quinoline derivative
KR940006531B1 (en) Process for preparation of pyridine derivatives
JPH1129540A (en) Production of ester derivative
HU195659B (en) Process for producing cotarnine
JPS62126164A (en) 4-alkoxy-2-oxo-pyrrolidine-1 acetic acid alkyl ester and manufacture
KR970008316B1 (en) Preparation process for pyridine derivatives
JP2853929B2 (en) Method for producing 2-chloro-4,5-difluoro-3-methoxybenzoic acid
JP2743198B2 (en) Cyclopentanes
JP3852491B2 (en) 2-cyanopiperazine and method for producing the same
JPS6026395B2 (en) Synthesis method of N-trialkylsilylmethylurea
JP3037816B2 (en) Preparation of pyranoindolizinedione derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E801 Decision on dismissal of amendment
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19990420

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee